마취통증의학과
이원형 교수
- [전문분야]
- 만성통증, 대상포진후신경통, 근육통, 요통, 좌골신경통 관리
- [전문진료]
- 만성통증 치료 및 마취
당신의 기쁨이 저의 희망입니다
오늘도 건강하신가요? 인생의 시간중에서 가장 젊은 오늘, 혹시 만성통증으로 고생하고 계시진 않나요. 제가 가장 젊게 지내시도록 당신의 통증을 완화시켜 드리겠습니다.
논문
- 표창장 2014년 보건복지부 한국지역임상센터사업 Center of Excellence 선정
Marquis Who’s Who 세계 인명 사전 등재
논문 (최근 5년)
1. Employing the sustained-release properties of poly(lactic-co-glycolic acid) nanoparticles to reveal a novel mechanism of sodium-hydrogen exchanger 1 in neuropathic pain. Transl Res. 2023 Sep 9.
2. IKBKBsiRNA-Encapsulated Poly (Lactic-co-Glycolic Acid) Nanoparticles Diminish Neuropathic Pain by Inhibiting Microglial Activation.Int J Mol Sci. 2021 May 26;22(11):5657.
3. Application of PLGA nanoparticles to enhance the action of duloxetine on microglia in neuropathic pain.Biomater Sci. 2021 Sep 14;9(18):6295-6307. doi: 10.1039/d1bm00486g.
4. NFAT5 Deficiency Alleviates Formalin-Induced Inflammatory Pain Through mTOR.. March 2021 International Journal of Molecular Sciences 22(5):2587.DOI: 10.3390/ijms22052587
5. CX3CR1-Targeted PLGA Nanoparticles Reduce Microglia Activation and Pain Behavior in Rats with Spinal Nerve Ligation May 2020 International Journal of Molecular Sciences 21(10):3469.
6. The mTOR Inhibitor Rapamycin Prevents General Anesthesia-Induced Changes in Synaptic Transmission and Mitochondrial Respiration in Late Postnatal Mice. January 2020 Frontiers in Cellular Neuroscience 14:4.
7. Evans Blue Reduces Neuropathic Pain Behavior by Inhibiting Spinal ATP Release. Int J Mol Sci.. 2019 Sep 9;20(18):4443.
8. , Comparison of laryngeal mask airway supremeTM as non-inflatable cuff device and self-pressurized air-QTM in children: Randomized controlled non-inferiority study, March 2019Medicine 98(10):e14746
교과서 편집
대한마취통증의학 4판 2022 05
대한통증의학 1판, 2판, 3판, 4판, 5판
특허등록
1) 에반스 블루를 포함하는 만성통증질환 예발 혹은 치료용 조성물.....
특허 제 10-1841951 호 2018. 3. 20 대한민국 특허청
2) COMPOSITION FOR PREVENTION OR TREATMENT OF CHRONIC PAIN
COMPRISING EVANS BLUE. USA 10,624,866 B, Apr. 2. 2020
